Kirk Siderman-Wolter

Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom.

Centre for Process Innovation Ltd (CPI) is a venture capital firm founded in 2019. The firm is headquartered in Redcar, United Kingdom.

PolyPhotonix Ltd. is a bio-photonic research and British development company that specializes in designing, developing, and manufacturing noninvasive photonic-based medical devices. The company is based in Sedgefield, UK. The company's focus is on light therapy treatments for macular eye disease. PolyPhotonix's most notable product is the Noctura 400 sleep mask, which is an innovative, noninvasive, and monitored home care treatment developed to prevent and treat diabetic retinopathy. The company was founded in 2008 by Richard Kirk, who has been the CEO since its inception.